Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Second Sight Medical Products Inc    EYES

SECOND SIGHT MEDICAL PRODUCTS INC

(EYES)
  Report  
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector news

SECOND SIGHT MEDICAL PRODUCTS INC : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
06/25/2019 | 04:04pm EDT

ITEM 7.01. REGULATION FD DISCLOSURE

A copy of a slide presentation that Nader Pouratian, MD, Ph.D. a researcher in the study of the Orion Cortical Visual Prosthesis from Second Sight Medical Products, Inc. ("Second Sight") intends to use during a presentation at the World Society for Steriotactic and Functional Neurosurgery (WSSFN) Conference in New York City on June 25, 2019 (the "Presentation Materials") is attached to this Current Report on Form 8-K as Exhibit 99.2, and is incorporated by reference herein. The Presentation Materials speak as of the date of this Current Report on Form 8-K. While Second Sight may elect to update the Presentation Materials in the future or reflect events and circumstances occurring or existing after the date of this Current Report on Form 8-K, Second Sight specifically disclaims any obligation to do so. The information contained in this Item 7.01 and Exhibit 99.1 hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by reference in such a filing.


ITEM 8.01 Other Events


On June 25, 2019, Second Sight issued a press release entitled "Researchers Present Latest Positive Results of Second Sight's Orion Visual Cortical Prosthesis Feasibility Study". In the release, Second Sight stated that the study's principal investigators, Nader Pouratian, MD, Ph.D. of Ronald Reagan UCLA Medical Center and Daniel Yoshor, MD of Baylor College of Medicine are presenting the topline data. Orion is a breakthrough technology intended to provide useful artificial vision to individuals who are blind due to a wide range of causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. Orion converts images captured by a miniature video camera mounted on glasses into a series of small electrical pulses transmitted wirelessly to electrodes implanted directly on the visual cortex of the individual subject's brain. A copy of the press release is attached to this current report on Form 8-K as exhibit 99.1 and incorporated herein by this reference.

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS

Exhibit No. Description

99.1 Press Release titled " Researchers Present Latest Positive Results of Second Sight's Orion Visual Cortical Prosthesis Feasibility Study" , dated June 25, 2019.

99.2 Presentation titled " Development of a Visual Prosthesis: The Orion Visual Prosthesis System ", dated June 25, 2019.

© Edgar Online, source Glimpses

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on SECOND SIGHT MEDICAL PRODU
06/25SECOND SIGHT MEDICAL PRODUCTS : Researchers Present Latest Positive Results of S..
BU
06/25SECOND SIGHT MEDICAL PRODUCTS INC : Regulation FD Disclosure, Other Events, Fina..
AQ
06/05SECOND SIGHT MEDICAL PRODUCTS INC : Submission of Matters to a Vote of Security ..
AQ
05/23SECOND SIGHT MEDICAL PRODUCTS INC : Regulation FD Disclosure, Financial Statemen..
AQ
05/16SECOND SIGHT MEDICAL PRODUCTS : to Present at 20th Annual B. Riley FBR Investor ..
BU
05/15SECOND SIGHT MEDICAL PRODUCTS INC : Results of Operations and Financial Conditio..
AQ
05/15SECOND SIGHT MEDICAL PRODUCTS INC : Other Events, Financial Statements and Exhib..
AQ
05/15SECOND SIGHT MEDICAL PRODUCTS : Management's Discussion and Analysis of Financia..
AQ
05/15SECOND SIGHT MEDICAL PRODUCTS : 1Q Earnings Snapshot
AQ
05/15SECOND SIGHT MEDICAL PRODUCTS : Reports First Quarter 2019 Financial Results
BU
More news
Financials (USD)
Sales 2019 2,15 M
EBIT 2019 -35,7 M
Net income 2019 -35,5 M
Debt 2019 -
Yield 2019 -
P/E ratio 2019 -2,90x
P/E ratio 2020 -3,33x
Capi. / Sales2019 51,9x
Capi. / Sales2020 241x
Capitalization 112 M
Chart SECOND SIGHT MEDICAL PRODUCTS INC
Duration : Period :
Second Sight Medical Products Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SECOND SIGHT MEDICAL PRODU
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Average target price 2,50  $
Last Close Price 0,90  $
Spread / Highest target 178%
Spread / Average Target 178%
Spread / Lowest Target 178%
EPS Revisions
Managers
NameTitle
Jonathan Will McGuire President, Chief Executive Officer & Director
Gregg G. Williams Chairman
William Patrick Ryan Chief Operating Officer
John T. Blake Chief Financial Officer & Secretary
Edward Randolph VP-Operations, Quality & Information Technology
Sector and Competitors
1st jan.Capitalization (M$)
SECOND SIGHT MEDICAL PRODUCTS INC1.64%112
STRYKER CORPORATION32.71%77 613
SMITH & NEPHEW18.37%18 916
WRIGHT MEDICAL GROUP NV-0.29%3 423
GLAUKOS CORP33.77%2 735
INSPIRE MEDICAL SYSTEMS INC60.26%1 612